Milestone Pharmaceuticals Inc. — All Filings
395 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001493152-26-013007 | Mar 26, 2026 | — |
| 3 | — | 0002012430-26-000002 | Mar 23, 2026 | Mar 17, 2026 |
| 8-K | FORM 8-K | 0001104659-26-032427 | Mar 20, 2026 | — |
| 10-K | 10-K | 0001104659-26-032415 | Mar 20, 2026 | Dec 31, 2025 |
| 4/A | — | 0001437782-26-000007 | Feb 5, 2026 | Feb 2, 2026 |
| 4/A | — | 0001910985-26-000006 | Feb 5, 2026 | Feb 2, 2026 |
| 4/A | — | 0001943112-26-000005 | Feb 5, 2026 | Feb 2, 2026 |
| 4/A | — | 0001771207-26-000005 | Feb 5, 2026 | Feb 2, 2026 |
| 4/A | — | 0001787700-26-000005 | Feb 5, 2026 | Feb 2, 2026 |
| 4 | — | 0001771207-26-000004 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001787700-26-000004 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001943112-26-000004 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001910985-26-000005 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001437782-26-000006 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001910985-26-000003 | Jan 28, 2026 | Dec 12, 2025 |
| 4 | — | 0001943112-26-000002 | Jan 28, 2026 | Dec 12, 2025 |
| 4 | — | 0001771207-26-000002 | Jan 28, 2026 | Dec 12, 2025 |
| 4 | — | 0001787700-26-000002 | Jan 28, 2026 | Dec 12, 2025 |
| 4 | — | 0001437782-26-000004 | Jan 28, 2026 | Dec 12, 2025 |
| 8-K | FORM 8-K | 0001104659-26-006483 | Jan 26, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-003038 | Jan 13, 2026 | Jan 12, 2026 |
| 4 | — | 0001437782-26-000002 | Jan 9, 2026 | Jan 7, 2026 |
| 144 | — | 0001950047-26-000282 | Jan 8, 2026 | — |
| 144 | — | 0001950047-26-000231 | Jan 7, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-001099 | Jan 6, 2026 | — |
| SCHEDULE 13G | — | 0001969764-25-000003 | Dec 23, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-120904 | Dec 15, 2025 | Dec 12, 2025 |
| 4 | — | 0001771207-25-000002 | Dec 11, 2025 | Dec 9, 2025 |
| SCHEDULE 13G/A | — | 0001493152-25-023424 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001493215-25-000045 | Nov 14, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-004894 | Nov 13, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-109744 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001104659-25-109689 | Nov 12, 2025 | Sep 30, 2025 |
| S-8 | FORM S-8 | 0001104659-25-076479 | Aug 12, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-076468 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-011141 | Aug 12, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | — | 0001641172-25-020404 | Jul 21, 2025 | — |
| 4 | — | 0001415889-25-019776 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001415889-25-019775 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001415889-25-019774 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001415889-25-019773 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001415889-25-019772 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001415889-25-019771 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001415889-25-019770 | Jul 15, 2025 | Jul 11, 2025 |
| 8-K | FORM 8-K | 0001104659-25-067579 | Jul 14, 2025 | Jul 11, 2025 |
| 424B5 | 424B5 | 0001104659-25-067502 | Jul 14, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-067130 | Jul 11, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-067108 | Jul 11, 2025 | Jul 10, 2025 |
| 8-K | FORM 8-K | 0001104659-25-059671 | Jun 16, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-058874 | Jun 12, 2025 | Jun 10, 2025 |